[
  {
    "ts": null,
    "headline": "Medtronic (MDT) Q2 2025 Earnings Call Transcript",
    "summary": "MDT earnings call for the period ending September 30, 2024.",
    "url": "https://finnhub.io/api/news?id=8b1f25b118cecb07ba96049723f8d40b58f2d2498971dba82b85b21353fb399a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732047310,
      "headline": "Medtronic (MDT) Q2 2025 Earnings Call Transcript",
      "id": 131504697,
      "image": "https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "MDT earnings call for the period ending September 30, 2024.",
      "url": "https://finnhub.io/api/news?id=8b1f25b118cecb07ba96049723f8d40b58f2d2498971dba82b85b21353fb399a"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic Q2 Earnings: Diabetes And Neuroscience Revenue Boost Growth, Raises Annual Outlook",
    "summary": "Tuesday, Medtronic Plc (NYSE:MDT) reported second-quarter 2025 sales of $8.40 billion, beating the consensus of $8.27 billion. The medical device maker reported adjusted EPS of $1.26, beating the consensus of $1.25. Revenue increased 5.3% year over year, as reported, and 5% on an organic basis. Also Read: Medtronic Recalls MiniMed Pump Due To Battery Life Concerns Cardiovascular segment revenue reached $3.102 billion, up 6.1% year over year as reported, and increased 5.6% organically, with a hig",
    "url": "https://finnhub.io/api/news?id=3cf5743b3d668c7ec14f5ad4b376cac456059a17dd2b5fea188eb4bc256460e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732036385,
      "headline": "Medtronic Q2 Earnings: Diabetes And Neuroscience Revenue Boost Growth, Raises Annual Outlook",
      "id": 131488330,
      "image": "https://media.zenfs.com/en/Benzinga/fa9ede61c433f95c903f0392be8eff07",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Tuesday, Medtronic Plc (NYSE:MDT) reported second-quarter 2025 sales of $8.40 billion, beating the consensus of $8.27 billion. The medical device maker reported adjusted EPS of $1.26, beating the consensus of $1.25. Revenue increased 5.3% year over year, as reported, and 5% on an organic basis. Also Read: Medtronic Recalls MiniMed Pump Due To Battery Life Concerns Cardiovascular segment revenue reached $3.102 billion, up 6.1% year over year as reported, and increased 5.6% organically, with a hig",
      "url": "https://finnhub.io/api/news?id=3cf5743b3d668c7ec14f5ad4b376cac456059a17dd2b5fea188eb4bc256460e3"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic PLC stock underperforms Tuesday when compared to competitors",
    "summary": "Medtronic PLC stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=d673f1ce3cdb5a13aa07072374c18f0de2d50227d709099317f5b0ebc4592760",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732034520,
      "headline": "Medtronic PLC stock underperforms Tuesday when compared to competitors",
      "id": 131509321,
      "image": "",
      "related": "MDT",
      "source": "MarketWatch",
      "summary": "Medtronic PLC stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=d673f1ce3cdb5a13aa07072374c18f0de2d50227d709099317f5b0ebc4592760"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic's Stock Dips Despite Innovation Surge: What Investors Need to Know",
    "summary": "Diabetes shines, cardiac ablation stumbles, and new products spark hope--Medtronic's Q2 FY25 shakes up expectations.",
    "url": "https://finnhub.io/api/news?id=e1ce9604a84430a7354447d26dfb019572323b5dee5cc9498c8b5a76ceb2a1dc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732033654,
      "headline": "Medtronic's Stock Dips Despite Innovation Surge: What Investors Need to Know",
      "id": 131488332,
      "image": "https://media.zenfs.com/en/us.finance.gurufocus/e4f159bd333b4507808ad8747ddfc446",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Diabetes shines, cardiac ablation stumbles, and new products spark hope--Medtronic's Q2 FY25 shakes up expectations.",
      "url": "https://finnhub.io/api/news?id=e1ce9604a84430a7354447d26dfb019572323b5dee5cc9498c8b5a76ceb2a1dc"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing",
    "summary": "Medtronic plc's Q2 earnings show moderate growth, highlighting potential for shareholder value through strategic initiatives. Click for my MDT earnings update.",
    "url": "https://finnhub.io/api/news?id=cb70e44216c714bef8a7441b53cfd98007a91bda8cbcf528aa6a02cb47ec9023",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732028645,
      "headline": "Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing",
      "id": 131489356,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1796947698/image_1796947698.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "Medtronic plc's Q2 earnings show moderate growth, highlighting potential for shareholder value through strategic initiatives. Click for my MDT earnings update.",
      "url": "https://finnhub.io/api/news?id=cb70e44216c714bef8a7441b53cfd98007a91bda8cbcf528aa6a02cb47ec9023"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic Flirts With A Sell Zone After Supplier Issue Trumps Beat And Raise",
    "summary": "Medtronic beat quarterly expectations Tuesday, but Medtronic stock dipped near a sell zone in early trading.",
    "url": "https://finnhub.io/api/news?id=7b63418dc521ee1637653198299c872a165baa092f63c7bdd1ffffc8677e6da2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732028557,
      "headline": "Medtronic Flirts With A Sell Zone After Supplier Issue Trumps Beat And Raise",
      "id": 131488333,
      "image": "",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic beat quarterly expectations Tuesday, but Medtronic stock dipped near a sell zone in early trading.",
      "url": "https://finnhub.io/api/news?id=7b63418dc521ee1637653198299c872a165baa092f63c7bdd1ffffc8677e6da2"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic Q2 Earnings and Revenues Top, Stock Down on Trimmed '25 View",
    "summary": "MDT delivers diversified growth across all its segments in the second quarter of fiscal 2025.",
    "url": "https://finnhub.io/api/news?id=2681e5ea47cc42588990163a71ed27aca1b2575584fe45f126cacc231c33ca28",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732026660,
      "headline": "Medtronic Q2 Earnings and Revenues Top, Stock Down on Trimmed '25 View",
      "id": 131488334,
      "image": "https://media.zenfs.com/en/zacks.com/0e6e00119767dea571e2db52c929df03",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "MDT delivers diversified growth across all its segments in the second quarter of fiscal 2025.",
      "url": "https://finnhub.io/api/news?id=2681e5ea47cc42588990163a71ed27aca1b2575584fe45f126cacc231c33ca28"
    }
  },
  {
    "ts": null,
    "headline": "Compared to Estimates, Medtronic (MDT) Q2 Earnings: A Look at Key Metrics",
    "summary": "Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended October 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finnhub.io/api/news?id=b32229cc9233795910b41fd0e06ebfcfd92be622284725eabe9b34986ba1de95",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732026609,
      "headline": "Compared to Estimates, Medtronic (MDT) Q2 Earnings: A Look at Key Metrics",
      "id": 131488336,
      "image": "https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended October 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
      "url": "https://finnhub.io/api/news?id=b32229cc9233795910b41fd0e06ebfcfd92be622284725eabe9b34986ba1de95"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic (MDT) Surpasses Q2 Earnings and Revenue Estimates",
    "summary": "Medtronic (MDT) delivered earnings and revenue surprises of 1.61% and 1.75%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=d03c44ec476aa98c1a6c515eb3fc342b4d9be56918322befabfa1aef020474d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732020902,
      "headline": "Medtronic (MDT) Surpasses Q2 Earnings and Revenue Estimates",
      "id": 131488339,
      "image": "https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic (MDT) delivered earnings and revenue surprises of 1.61% and 1.75%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=d03c44ec476aa98c1a6c515eb3fc342b4d9be56918322befabfa1aef020474d4"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic lifts annual profit view on strong demand for medical devices",
    "summary": "The Ireland-based company expects profit in the range of $5.44 to $5.50 per share for fiscal year 2025, compared with its earlier forecast of $5.42 to $5.50.  Investors had set a high bar for results from medical device makers as the companies continue to benefit from healthy demand for non-urgent surgeries, especially among older Americans, over the last few quarters.  Peers Boston Scientific and Abbott had also raised their annual profit forecasts last month.",
    "url": "https://finnhub.io/api/news?id=c07345a0484e1d71d59f5dacdf8b6af2f6618b382f6a0a3eb63612b984834a32",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732018672,
      "headline": "Medtronic lifts annual profit view on strong demand for medical devices",
      "id": 131469133,
      "image": "https://media.zenfs.com/en/reuters-finance.com/0033543e86f8d753401190e5fa2f1d22",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The Ireland-based company expects profit in the range of $5.44 to $5.50 per share for fiscal year 2025, compared with its earlier forecast of $5.42 to $5.50.  Investors had set a high bar for results from medical device makers as the companies continue to benefit from healthy demand for non-urgent surgeries, especially among older Americans, over the last few quarters.  Peers Boston Scientific and Abbott had also raised their annual profit forecasts last month.",
      "url": "https://finnhub.io/api/news?id=c07345a0484e1d71d59f5dacdf8b6af2f6618b382f6a0a3eb63612b984834a32"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic narrows annual earnings forecast, raises organic revenue growth outlook",
    "summary": "Medtronic (NYSE:MDT) narrowed its annual earnings forecast for the fiscal 2025 year but raised the organic revenue growth outlook. The company’s shares rose nearly 1% in premarket trading Tuesday.",
    "url": "https://finnhub.io/api/news?id=c0d43cb800041bbf3d00777151d8586031ca78c2d948435cda05313a2020d9f5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732018404,
      "headline": "Medtronic narrows annual earnings forecast, raises organic revenue growth outlook",
      "id": 131469134,
      "image": "",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic (NYSE:MDT) narrowed its annual earnings forecast for the fiscal 2025 year but raised the organic revenue growth outlook. The company’s shares rose nearly 1% in premarket trading Tuesday.",
      "url": "https://finnhub.io/api/news?id=c0d43cb800041bbf3d00777151d8586031ca78c2d948435cda05313a2020d9f5"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic: Fiscal Q2 Earnings Snapshot",
    "summary": "DUBLIN (AP) — Medtronic PLC (MDT) on Tuesday reported fiscal second-quarter net income of $1.27 billion. The Dublin-based company said it had net income of 99 cents per share. Earnings, adjusted for one-time gains and costs, were $1.26 per share.",
    "url": "https://finnhub.io/api/news?id=ade668544511b1231f10b44d6213efc6de1913e35c0d51edfa2e6cf9838e8507",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732017310,
      "headline": "Medtronic: Fiscal Q2 Earnings Snapshot",
      "id": 131469135,
      "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "DUBLIN (AP) — Medtronic PLC (MDT) on Tuesday reported fiscal second-quarter net income of $1.27 billion. The Dublin-based company said it had net income of 99 cents per share. Earnings, adjusted for one-time gains and costs, were $1.26 per share.",
      "url": "https://finnhub.io/api/news?id=ade668544511b1231f10b44d6213efc6de1913e35c0d51edfa2e6cf9838e8507"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic’s ablation sales slowed by PFA supply issues",
    "summary": "CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues that have now been resolved.",
    "url": "https://finnhub.io/api/news?id=66300a4e7f7fca21318517d7dcd57a29b615c0a7de075079af38e9130f0bf981",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732016880,
      "headline": "Medtronic’s ablation sales slowed by PFA supply issues",
      "id": 131488351,
      "image": "https://imgproxy.divecdn.com/jka0Z1D-QjBEzHrikJvCdCsaqfaA6J0skG82uj3p5WE/g:nowe:0:29/c:1000:564/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL01lZHRyb25pYy40LjI2LjI0LjdfMTAwMC5qcGc=.webp",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues that have now been resolved.",
      "url": "https://finnhub.io/api/news?id=66300a4e7f7fca21318517d7dcd57a29b615c0a7de075079af38e9130f0bf981"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic reports second quarter fiscal 2025 financial results",
    "summary": "Medtronic plc (NYSE: MDT) today announced financial results for its second quarter (Q2) of fiscal year 2025 (FY25), which ended October 25, 2024.",
    "url": "https://finnhub.io/api/news?id=b21a10d7cb1a918ff8dc374b548cc97d5dc5fe1b7806beabde8e2232e5452a55",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732016700,
      "headline": "Medtronic reports second quarter fiscal 2025 financial results",
      "id": 131469136,
      "image": "https://media.zenfs.com/en/prnewswire.com/f42cff9e2db69dfda303106273a6925a",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic plc (NYSE: MDT) today announced financial results for its second quarter (Q2) of fiscal year 2025 (FY25), which ended October 25, 2024.",
      "url": "https://finnhub.io/api/news?id=b21a10d7cb1a918ff8dc374b548cc97d5dc5fe1b7806beabde8e2232e5452a55"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic plc (MDT) Q2 2025 Earnings Call Transcript",
    "summary": "Medtronic plc (NYSE:MDT) Q2 2025 Earnings Conference Call November 19, 2024 8:00 AM ETCompany ParticipantsRyan Weispfenning - VP and Head, IRGeoff Martha -...",
    "url": "https://finnhub.io/api/news?id=91ee2be72871d3e94b6a8e2d73bbf923b339c7ac9b56c34a13d01904dab328a6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732014262,
      "headline": "Medtronic plc (MDT) Q2 2025 Earnings Call Transcript",
      "id": 131472770,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "Medtronic plc (NYSE:MDT) Q2 2025 Earnings Conference Call November 19, 2024 8:00 AM ETCompany ParticipantsRyan Weispfenning - VP and Head, IRGeoff Martha -...",
      "url": "https://finnhub.io/api/news?id=91ee2be72871d3e94b6a8e2d73bbf923b339c7ac9b56c34a13d01904dab328a6"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic: annual targets further tightened",
    "summary": "On the occasion of its quarterly publication, Medtronic now targets non-GAAP EPS of between $5.44 and $5.50 for its full 2024-25 financial year, compared with its previous target range of $5.42 to...",
    "url": "https://finnhub.io/api/news?id=acfe72d2f4b2fa5dcdbfc76ad8c19bbfb6d7b7802b583d49b7de3be610f7a9d5",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732001713,
      "headline": "Medtronic: annual targets further tightened",
      "id": 131469407,
      "image": "",
      "related": "MDT",
      "source": "Finnhub",
      "summary": "On the occasion of its quarterly publication, Medtronic now targets non-GAAP EPS of between $5.44 and $5.50 for its full 2024-25 financial year, compared with its previous target range of $5.42 to...",
      "url": "https://finnhub.io/api/news?id=acfe72d2f4b2fa5dcdbfc76ad8c19bbfb6d7b7802b583d49b7de3be610f7a9d5"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic Narrows Fiscal Year Guidance as 2Q Tops Views",
    "summary": "By Adriano Marchese Medtronic narrowed its full-year guidance after topping expectations in its fiscal second quarter thanks to a strong performance across its portfolios. The medical...",
    "url": "https://finnhub.io/api/news?id=a010b21ace4e8176720497ba0443767a88ad3de623b5ca7871655fa200566711",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732001259,
      "headline": "Medtronic Narrows Fiscal Year Guidance as 2Q Tops Views",
      "id": 131469348,
      "image": "",
      "related": "MDT",
      "source": "Finnhub",
      "summary": "By Adriano Marchese Medtronic narrowed its full-year guidance after topping expectations in its fiscal second quarter thanks to a strong performance across its portfolios. The medical...",
      "url": "https://finnhub.io/api/news?id=a010b21ace4e8176720497ba0443767a88ad3de623b5ca7871655fa200566711"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic Narrows FY Guidance as 2Q Tops Views",
    "summary": "Medtronic Narrows FY Guidance as 2Q Tops Views",
    "url": "https://finnhub.io/api/news?id=74f06f0ea8ddb4fbae5c1a68b2078356f8154dd27c482e7143cd13bec4ea6f1e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732000320,
      "headline": "Medtronic Narrows FY Guidance as 2Q Tops Views",
      "id": 131476246,
      "image": "",
      "related": "MDT",
      "source": "MarketWatch",
      "summary": "Medtronic Narrows FY Guidance as 2Q Tops Views",
      "url": "https://finnhub.io/api/news?id=74f06f0ea8ddb4fbae5c1a68b2078356f8154dd27c482e7143cd13bec4ea6f1e"
    }
  },
  {
    "ts": null,
    "headline": "Innovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation Form 8 K",
    "summary": "Innovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation GALWAY, Ireland - Nov. 19, 2024 -...",
    "url": "https://finnhub.io/api/news?id=a8d08cc97328de8dfa938e6767358460c8003aac0c9145656dc0998d484823f4",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731999006,
      "headline": "Innovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation Form 8 K",
      "id": 131468643,
      "image": "",
      "related": "MDT",
      "source": "Finnhub",
      "summary": "Innovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation GALWAY, Ireland - Nov. 19, 2024 -...",
      "url": "https://finnhub.io/api/news?id=a8d08cc97328de8dfa938e6767358460c8003aac0c9145656dc0998d484823f4"
    }
  },
  {
    "ts": null,
    "headline": "Walmart headlines earning slate",
    "summary": "Walmart headlines earning slate",
    "url": "https://finnhub.io/api/news?id=210ca5b0ecd13e3f485710b9129111c7914f4259686dcecc4016190959fffd7e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731993958,
      "headline": "Walmart headlines earning slate",
      "id": 131473188,
      "image": "",
      "related": "MDT",
      "source": "MarketWatch",
      "summary": "Walmart headlines earning slate",
      "url": "https://finnhub.io/api/news?id=210ca5b0ecd13e3f485710b9129111c7914f4259686dcecc4016190959fffd7e"
    }
  }
]